High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements
1 clinical trials · Condition
◉ Watch High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements
| Record | Firm | Date |
|---|---|---|
| Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma (NCT04479267) | Barbara Ann Karmanos Cancer Institute | 2020-08-21 |
Track High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements automatically
Every clearance here is in the API, with alerts when new ones post.